Yaron Barac to Prospective Studies
This is a "connection" page, showing publications Yaron Barac has written about Prospective Studies.
Connection Strength
0.121
-
Shaul AA, Itzhaki Ben Zadok O, Ben-Avraham B, Yaari V, Barsheshet A, Levi A, Ben Zvi H, Eliakim Raz N, Abed G, Abuhazira M, Abu Akel M, Mats I, Barac YD, Aravot D, Kornowski R, Ben-Gal T. Improved immunogenicity following the third dose of BNT162b2 mRNA vaccine in heart transplant recipients. Eur J Cardiothorac Surg. 2022 Sep 02; 62(4).
Score: 0.032
-
Itzhaki Ben Zadok O, Shaul AA, Ben-Avraham B, Yaari V, Ben Zvi H, Eliakim-Raz N, Yahav D, Abed G, Abuhazira M, Barac YD, Mats I, Shochat T, Aravot D, Kornowski R, Ben-Gal T. Six-months immunogenicity of BNT162b2 mRNA vaccine in heart transplanted and ventricle assist device-supported patients. ESC Heart Fail. 2022 Apr; 9(2):905-911.
Score: 0.031
-
Itzhaki Ben Zadok O, Shaul AA, Ben-Avraham B, Yaari V, Ben Zvi H, Shostak Y, Pertzov B, Eliakim-Raz N, Abed G, Abuhazira M, Barac YD, Mats I, Kramer MR, Aravot D, Kornowski R, Ben-Gal T. Immunogenicity of the BNT162b2 mRNA vaccine in heart transplant recipients - a prospective cohort study. Eur J Heart Fail. 2021 Sep; 23(9):1555-1559.
Score: 0.029
-
Witberg G, Segev A, Barac YD, Raanani E, Assali A, Finkelstein A, Roguin A, Sahar G, Vaknin-Assa H, Bolotin G, Eitan A, Klempfner R, Goldenberg I, Kornowski R. Heart Team/Guidelines Discordance Is Associated With Increased Mortality: Data From a National Survey of Revascularization in Patients With Complex Coronary Artery Disease. Circ Cardiovasc Interv. 2021 Jan; 14(1):e009686.
Score: 0.029